Clinical, Cosmetic and Investigational Dermatology Dovepress New Developments in the Treatment of Rosacea – Role of Once-daily Ivermectin Cream

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors.

  2015cited by this paper
• Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments

  2015cited by this paper
• Rosacea: part II. Topical and systemic therapies in the treatment of rosacea.

  2015cited by this paper
• Assessment of rosacea severity: A review of evaluation methods used in clinical trials.

  2015cited by this paper
• Ivermectin cream (Soolantra) for rosacea.

  2015cited by this paper
• Superiority of ivermectin 1% cream over metronidazole 0·75% cream in treating inflammatory lesions of rosacea: a randomized, investigator‐blinded trial

  2015cited by this paper
• An emerging treatment: Topical ivermectin for papulopustular rosacea

  2015cited by this paper
• The treatment of rosacea with topical ivermectin.

  2015cited by this paper
• Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.

  2014cited by this paper
• Rosacea: New and Emerging Treatments

  2014cited by this paper
• Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.

  2014cited by this paper
• Crusted Demodicosis in an Immunocompetent Pediatric Patient

  2014cited by this paper
• Patterns of ambulatory care usage and leading treatments for rosacea

  2014cited by this paper
• Therapeutic update on Rosacea.

  2014cited by this paper
• Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin.

  2014cited by this paper
• Emerging therapies in rosacea.

  2013cited by this paper
• New insights into rosacea pathophysiology: a review of recent findings.

  2013cited by this paper
• Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.

  2013cited by this paper
• Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.

  2013cited by this paper
• Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link

  2012cited by this paper
• Potential role of Demodex mites and bacteria in the induction of rosacea.

  2012cited by this paper
• The potential role of microorganisms in the development of rosacea

  2011cited by this paper
• The role of Helicobacter pylori infection in skin diseases: facts and controversies.

  2010cited by this paper
• A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.

  2009cited by this paper
• The pathophysiology of rosacea.

  2009cited by this paper
• Azelaic acid 15% gel once daily versus twice daily in papulopustular rosacea.

  2008cited by this paper
• Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin.

  2007cited by this paper
• The CLEAR trial: results of a large community-based study of metronidazole gel in rosacea.

  2007cited by this paper
• Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea.

  2006cited by this paper
• Temperature regulates bacterial protein production: possible role in rosacea.

  2004cited by this paper
• Clinical and Laboratory Investigations Epithelial barrier function and atopic diathesis in rosacea and perioral dermatitis

  2004cited by this paper
• Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies.

  2003cited by this paper
• A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.

  2003cited by this paper
• Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea.

  2001cited by this paper
• Treatment of rosacea-like demodicidosis with oral ivermectin and topical permethrin cream.

  1999cited by this paper
• A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulopustular rosacea.

  1999cited by this paper
• The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial.

  1998cited by this paper
• Topical metronidazole therapy for rosacea.

  1987cited by this paper

• Microbe-Host Interaction in Rosacea and its Modulation Through Topical Ivermectin.

  2025cites this paper
• Development and Characterization of Ivermectin Loaded Microneedle Formulations Using 3D Printed Molds.

  2025cites this paper
• An Adhesive Peptide Derived from Mussel Protein Alleviates LL37-Induced Rosacea Through Anti-Inflammatory and Anti-Angiogenic Mechanisms

  2025cites this paper
• Ivermectin-Loaded Mesoporous Silica and Polymeric Nanocapsules: Impact on Drug Loading, In Vitro Solubility Enhancement, and Release Performance

  2024cites this paper
• Prescriber Phenotypes: Variability in Topical Rosacea Treatment Patterns Among United States Dermatologists

  2024cites this paper
• A case of Morbihan disease treated with ivermectin

  2024cites this paper
• Efficacy of single-dose oral ivermectin in treatment of rosacea in relation to demodex mites

  2024cites this paper
• Impact of Ivermectin on the Gut Microbial Ecosystem

  2023cites this paper
• Diagnosis and Management of Common Inflammatory Skin Diseases in Older Adults.

  2023cites this paper
• Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases

  2022cites this paper
• Treatment strategies, including antibiotics, to target the immune component of rosacea

  2022cites this paper
• Demodex folliculorum and Demodex brevis (Acari: Demodecidae) and their association with facial and non-facial pathologies

  2021cites this paper
• Protein Function | Allostery in Proteins: Canonical Models and New Insights

  2021cites this paper
• Gut microbial communities modulate efficacy of albendazole-ivermectin against soil-transmitted helminthiases

  2021cites this paper
• The Importance of Assessing Burning and Stinging when Managing Rosacea: A Review

  2021cites this paper
• Manifestaciones cutáneas secundarias a la pandemia de COVID-19

  2021cites this paper
• Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature

  2021cites this paper
• Conventional and Novel Treatment Modalities in Rosacea

  2020cites this paper
• Coupled blue and red light-emitting diodes therapy efficacy in patients with rosacea: two case reports

  2020cites this paper
• Pulsed dye laser alone versus its combination with topical ivermectin 1% in treatment of Rosacea: a randomized comparative study

  2020cites this paper
• The use of NDYAG laser combined with pulsed light in the treatment of rosacea

  2020cites this paper
• The Pathogenic Role of Demodex Mites in Rosacea: A Potential Therapeutic Target Already in Erythematotelangiectatic Rosacea?

  2020cites this paper
• Cinnamtannin B1 attenuates rosacea-like signs via inhibition of pro-inflammatory cytokine production and down-regulation of the MAPK pathway

  2020cites this paper
• CCID_A_194074 179..186

  2020cites this paper
• Clinical picture, diagnosis and treatment of rosacea, complicated by Demodex mites

  2019cites this paper
• Clinical effectiveness of novel rosacea therapies.

  2019cites this paper
• Dermatika

  2019cites this paper
• Efficacy of topical ivermectin and impact on quality of life in patients with papulopustular rosacea: A systematic review and meta‐analysis

  2019cites this paper
• Methods for extraction and ex-vivo experimentation with the most complex human commensal, Demodex spp.

  2019cites this paper
• A comparison of the efficacy and tolerability of topical agents used in facial Demodex treatment

  2019cites this paper
• Ivermectin 1% (CD5024) for the treatment of rosacea

  2018cites this paper
• Immunomodulatory Effects of Antimicrobial Drugs

  2017cites this paper
• The Burden of Illness of Erythematotelangiectatic Rosacea and Papulopustular Rosacea: Findings From a Web-based Survey.

  2017cites this paper
• Demodex-Positive Acneiform Eruption Responsive to Ivermectin in a Patient Taking an Epidermal Growth Factor Inhibitor.

  2017cites this paper
• Neue Arzneimittel 2015

  2016cites this paper
• International Journal of Molecular Sciences Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition

  year unknowncites this paper